Donate
Australian & New Zealand Childrens Haematology/Oncology Group

ANZCHOG Children’s Cancer Clinical Trials Repository

Study Title
Stopping Tyrosine Kinase Inhibitors (TKI) to Assess Treatment-Free Remission (TFR) in Pediatric Chronic Myeloid Leukemia – Chronic Phase (CML-CP)
Protocol ID
AAML18P1
Disease (Sub Disease)
Chronic Myeloid Leukaemia
Diagnosis Stage
On treatment
Location
VIC
Sponsor
Children's Oncology Group
Collaborators
National Cancer Institute (NCI)
Trial Status
Open
Sites
Monash Children's Hospital
Study Type
Treatment
Phase
Phase 2
Age Eligibility
up to 25 years
International registry ID's
NCT03817398
Back to Registry
Study Title Stopping Tyrosine Kinase Inhibitors (TKI) to Assess Treatment-Free Remission (TFR) in Pediatric Chronic Myeloid Leukemia – Chronic Phase (CML-CP)
Protocol ID AAML18P1
Disease (Sub Disease) Chronic Myeloid Leukaemia
Diagnosis Stage On treatment
Location VIC
Sponsor Children's Oncology Group
Collaborators National Cancer Institute (NCI)
Links https://clinicaltrials.gov/ct2/show/NCT03817398
Trial Status Open
Trial Open Date 15/07/2019
Sites Monash Children's Hospital
Study Type Treatment
Phase Phase 2
Age Eligibility up to 25 years
International registry ID's NCT03817398